Table 2.
Socio-demographic characteristics by primary outcome measure of COVID-19-associated mortality and all-cause mortality, with the time under risk in person-years for each event stratified by the vaccine dose
Third-dose recipients
a
|
Fourth-dose recipients |
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Monovalent vaccine |
BA.1 bivalent vaccine |
BA.4–5 bivalent vaccine |
||||||||||||||||||||||
Person-time
b
|
COVID-19-associated mortality |
All-cause mortality |
Person-time
b
|
COVID-19-associated mortality |
All-cause mortality |
Person-time
b
|
COVID-19-associated mortality |
All-cause mortality |
Person-time
b
|
COVID-19-associated mortality |
All-cause mortality |
|||||||||||||
Years | % | n | % | n | % | Years | % | n | % | n | % | Years | % | n | % | n | % | Years | % | n | % | n | % | |
Sex | ||||||||||||||||||||||||
Female | 50 834 | 56.80% | 194 | 47.90% | 3503 | 53.10% | 61 365 | 55.22% | 154 | 49.52% | 3678 | 57.17% | 5314 | 53.44% | 4 | 50.0% | 115 | 48.12% | 2522 | 54.07% | 2 | 25.0% | 82 | 51.25% |
Male | 38 718 | 43.20% | 211 | 52.10% | 3095 | 46.90% | 49 758 | 44.78% | 157 | 50.48% | 2755 | 42.83% | 4630 | 46.56% | 4 | 50.0% | 124 | 51.88% | 2143 | 45.93% | 6 | 75.0% | 78 | 48.75% |
Age (years) | ||||||||||||||||||||||||
75–79 | 43 998 | 49.10% | 79 | 19.50% | 1510 | 22.90% | 51 701 | 46.53% | 57 | 18.33% | 1057 | 16.43% | 5648 | 56.80% | 2 | 25.0% | 61 | 25.52% | 2502 | 53.64% | 4 | 50.0% | 42 | 26.25% |
80–84 | 23 589 | 26.30% | 70 | 17.30% | 1446 | 21.90% | 31 723 | 28.55% | 58 | 18.65% | 1346 | 20.92% | 2444 | 24.57% | 2 | 25.0% | 41 | 17.15% | 1169 | 25.07% | 0 | – | 36 | 22.50% |
85–89 | 13 689 | 15.30% | 102 | 25.20% | 1605 | 24.30% | 17 388 | 15.65% | 82 | 26.37% | 1651 | 25.66% | 1230 | 12.37% | 1 | 12.5% | 73 | 30.54% | 636 | 13.63% | 2 | 25.0% | 42 | 26.25% |
90+ | 8275 | 9.20% | 154 | 38.00% | 2037 | 30.90% | 10 311 | 9.28% | 114 | 36.66% | 2379 | 36.98% | 623 | 6.26% | 3 | 37.5% | 64 | 27.00% | 358 | 8.00% | 2 | 25.0% | 40 | 25.00% |
Region | ||||||||||||||||||||||||
Innlandet | 8305 | 9.30% | 33 | 8.10% | 592 | 9.00% | 9157 | 8.00% | 31 | 9.97% | 570 | 8.86% | 1145 | 11.51% | 3 | 37.5% | 29 | 12.13% | 409 | 8.76% | 0 | – | 18 | 11.25% |
Trøndelag | 8205 | 9.20% | 27 | 6.70% | 604 | 9.20% | 10 046 | 9.04% | 27 | 8.68% | 596 | 9.26% | 847 | 8.52% | 1 | 12.5% | 23 | 9.62% | 281 | 6.01% | 1 | 12.5% | 10 | 6.25% |
Nord-Norge | 10 978 | 12.30% | 40 | 9.90% | 739 | 11.20% | 8403 | 7.56% | 22 | 7.07% | 514 | 7.99% | 1000 | 10.06% | 0 | 0.0% | 16 | 6.69% | 565 | 12.11% | 0 | – | 16 | 10.00% |
Oslo & Viken | 27 028 | 30.20% | 132 | 32.60% | 1948 | 29.50% | 38 520 | 34.66% | 109 | 35.05% | 2155 | 33.50% | 3004 | 30.21% | 2 | 25.0% | 68 | 28.45% | 1924 | 41.25% | 3 | 37.5% | 54 | 33.75% |
Agder & Sørøstlandet | 13 006 | 14.50% | 46 | 11.40% | 975 | 14.80% | 16 673 | 15.00% | 39 | 12.54% | 975 | 15.16% | 1473 | 14.81% | 0 | – | 27 | 11.30% | 739 | 15.85% | 3 | 37.5% | 39 | 24.38% |
Vestlandet | 22 031 | 24.60% | 127 | 31.40% | 1740 | 26.40% | 28 324 | 25.49% | 83 | 26.69% | 1623 | 25.23% | 2475 | 24.89% | 2 | 25.0% | 76 | 31.80% | 747 | 16.01% | 1 | 12.5% | 23 | 14.38% |
Risk group | ||||||||||||||||||||||||
None | 42 089 | 47.00% | 120 | 29.60% | 1929 | 29.20% | 51 804 | 46.62% | 113 | 36.00% | 2010 | 31.00% | 4741 | 48.00% | 3 | 37.5% | 76 | 31.80% | 2211 | 47.40% | 2 | 25.0% | 46 | 28.75% |
Medium | 41 036 | 45.80% | 220 | 54.30% | 3622 | 54.90% | 50 849 | 45.76% | 165 | 53.05% | 3555 | 55.26% | 4505 | 45.31% | 4 | 50.0% | 126 | 52.72% | 2120 | 45.45% | 5 | 62.5% | 91 | 56.88% |
High | 6427 | 7.20% | 65 | 16.00% | 1047 | 15.90% | 8469 | 7.62% | 33 | 10.61% | 868 | 13.49% | 698 | 7.02% | 1 | 12.5% | 37 | 15.00% | 334 | 7.00% | 1 | 12.5% | 23 | 14.00% |
LTCF resident | ||||||||||||||||||||||||
No | 86 319 | 96.40% | 277 | 68.40% | 5096 | 77.20% | 10 5061 | 94.55% | 163 | 52.41% | 3999 | 62.16% | 9829 | 98.85% | 8 | 100.0% | 213 | 89.12% | 4592 | 98.44% | 8 | 100.0% | 137 | 85.63% |
Yes | 3233 | 3.60% | 128 | 31.60% | 1502 | 22.80% | 6061 | 5.45% | 148 | 47.59% | 2434 | 37.84% | 115 | 1.16% | 0 | – | 26 | 10.88% | 73 | 1.56% | 0 | – | 23 | 14.38% |
LTCF, long-term care facility; COVID-19, coronavirus disease 2019; n, number.
Individuals who received their third dose >24 weeks ago.
The time under risk for third- and fourth-dose recipients until censoring or occurrence of the respective event.